Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
TAL Education Group ADR | TAL | Nov 15, 2024 | 9.84 | +4.13 |
Talen Energy | TLN | Nov 15, 2024 | 200.43 | -1.38 |
Talis Biomedical | TLIS | Nov 15, 2024 | 4.38 | 0.00 |
Talkspace | TALK | Nov 15, 2024 | 3.04 | -4.10 |
Talos Energy | TALO | Nov 15, 2024 | 11.28 | -3.26 |
Talphera | TLPH | Nov 15, 2024 | 0.69 | +4.23 |
Tamboran Resources | TBN | Nov 15, 2024 | 19.19 | +1.70 |
Tandem Diabetes Care | TNDM | Nov 15, 2024 | 27.34 | -4.37 |
Tanger | SKT | Nov 15, 2024 | 35.86 | +0.36 |
Tango Therapeutics | TNGX | Nov 15, 2024 | 3.85 | -1.79 |
Tantech | TANH | Nov 15, 2024 | 0.16 | -0.69 |
Taoping | TAOP | Nov 15, 2024 | 0.36 | -7.93 |
Tapestry | TPR | Nov 15, 2024 | 57.23 | -1.02 |
Targa Resources | TRGP | Nov 15, 2024 | 196.04 | +2.33 |
Target | TGT | Nov 15, 2024 | 152.13 | -0.87 |
Target Global Acquisition I A | TGAA | Nov 15, 2024 | 11.33 | 0.00 |
Target Global Acquisition I Unit | TGAAU | Nov 15, 2024 | 11.28 | 0.00 |
Target Hospitality | TH | Nov 15, 2024 | 9.07 | -2.21 |
Tarsus Pharmaceuticals | TARS | Nov 15, 2024 | 44.83 | -3.90 |
Taseko Mines | TGB | Nov 15, 2024 | 1.97 | -1.50 |
TaskUs A | TASK | Nov 15, 2024 | 13.76 | -0.86 |
TAT Technologies | TATT | Nov 15, 2024 | 20.61 | -7.08 |
Taylor Devices | TAYD | Nov 15, 2024 | 43.51 | -1.16 |
Taylor Morrison Home | TMHC | Nov 15, 2024 | 70.02 | -0.23 |
Taysha Gene Therapies | TSHA | Nov 15, 2024 | 2.06 | -9.25 |
TC Bancshares | TCBC | Nov 15, 2024 | 13.10 | 0.00 |
TC Biopharm ADR | TCBP | Nov 15, 2024 | 0.66 | +2.03 |
TC Energy | TRP | Nov 15, 2024 | 48.99 | +0.29 |
TCTM Kids IT Education ADR | TCTM | Nov 15, 2024 | 0.90 | +11.18 |
TCW Strategic | TSI | Nov 15, 2024 | 4.96 | +0.40 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.